Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 2401-2450 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT07116187
A Pilot Return-to-Work Cognitive Intervention After Stroke
NA
Recruiting
100 participants
Started: Aug 8, 2025 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT07124208
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
NA
Recruiting
46 participants
Started: Aug 8, 2025 · Completed: Aug 15, 2026
1 condition
1 sponsor
2 locations
NCT07001384
A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)
PHASE1
Recruiting
30 participants
Started: Aug 8, 2025 · Completed: Aug 8, 2031
2 conditions
3 sponsors
7 locations
NCT07141303
Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior Circulation Large Vessel Occlusion
PHASE3
Recruiting
1,060 participants
Started: Aug 8, 2025 · Completed: Jun 30, 2028
1 condition
6 sponsors
1 location
NCT07100158
Ultrasonographic Optic Nerve Sheath Diameter in Postdural Puncture Headache Diagnosis
N/A
Recruiting
190 participants
Started: Aug 8, 2025 · Completed: Dec 1, 2025
2 conditions
1 sponsor
1 location
NCT06948565
Prognosis of Cirrhotic Patients Admitted to the General Intensive Care Unit Between 2014 and 2024: a Regional Retrospective Multicentre Cohort Study
N/A
Recruiting
500 participants
Started: Aug 8, 2025 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT07039591
Assess Performance Attributes and Acceptability of Non-medicated Intravaginal Rings Among Sexually Active Women in Atlanta, GA
EARLY_PHASE1
Recruiting
60 participants
Started: Aug 8, 2025 · Completed: Oct 30, 2026
1 condition
2 sponsors
1 location
NCT07072832
Shelf Acetabuloplasty With 3D Printed Implants as a New Treatment for Symptomatic Adult Hip Dysplasia
NA
Recruiting
10 participants
Started: Aug 8, 2025 · Completed: Feb 29, 2028
1 condition
1 sponsor
1 location
NCT06974786
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
PHASE2
Recruiting
100 participants
Started: Aug 8, 2025 · Completed: Apr 30, 2033
2 conditions
3 sponsors
3 locations
NCT07099911
Neuromuscular Electrical Stimulation and Glucose Control in Spinal Cord Injury
NA
Recruiting
20 participants
Started: Aug 8, 2025 · Completed: Sep 1, 2027
1 condition
2 sponsors
1 location
NCT06912763
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
PHASE2
Recruiting
250 participants
Started: Aug 8, 2025 · Completed: Mar 1, 2033
4 conditions
1 sponsor
1 location
NCT07172516
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
PHASE3
Recruiting
400 participants
Started: Aug 8, 2025 · Completed: Aug 31, 2028
4 conditions
1 sponsor
9 locations
NCT07031531
Effectiveness of an AI-Enabled Stratified Management System for Premature Coronary Artery Disease
NA
Recruiting
4,900 participants
Started: Aug 8, 2025 · Completed: Jul 31, 2027
1 condition
1 sponsor
16 locations
NCT07099001
Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay
NA
Recruiting
150 participants
Started: Aug 8, 2025 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT07170644
A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)
PHASE2
Recruiting
18 participants
Started: Aug 8, 2025 · Completed: Dec 31, 2030
2 conditions
1 sponsor
2 locations
NCT06168058
Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices
NA
Recruiting
40 participants
Started: Aug 7, 2025 · Completed: Jun 30, 2026
5 conditions
4 sponsors
3 locations
NCT06691243
Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
PHASE2
Recruiting
40 participants
Started: Aug 7, 2025 · Completed: Mar 31, 2027
2 conditions
2 sponsors
2 locations
NCT06892093
Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients
NA
Recruiting
308 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2027
3 conditions
2 sponsors
1 location
NCT07098351
Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis
NA
Recruiting
93 participants
Started: Aug 7, 2025 · Completed: Jun 30, 2026
4 conditions
1 sponsor
1 location
NCT07067567
A Study of AK146D1 for Injection in Advanced Solid Tumors
PHASE1
Recruiting
200 participants
Started: Aug 7, 2025 · Completed: May 5, 2027
1 condition
1 sponsor
1 location
NCT07153159
A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding Women
PHASE1
Recruiting
8 participants
Started: Aug 7, 2025 · Completed: Oct 12, 2026
1 condition
1 sponsor
1 location
NCT06692192
The RECAP2 Study: Midazolam and Psilocybin
PHASE1
Recruiting
60 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT07162181
Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers
PHASE2
Recruiting
13 participants
Started: Aug 7, 2025 · Completed: May 31, 2030
3 conditions
1 sponsor
6 locations
NCT06981325
Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients
PHASE2
Recruiting
34 participants
Started: Aug 7, 2025 · Completed: Jul 31, 2029
2 conditions
4 sponsors
5 locations
NCT06963736
WatchWell: Simple and Practical Strategies to Reduce the Negative Health Impact of Sedentary Screen Time
NA
Recruiting
30 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT07079865
Effect of 60-day Peripheral Nerve Stimulation (PNS) in Alleviating Pain and Improving Function After Acute Thoracolumbar Compression Fracture
N/A
Recruiting
15 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2026
1 condition
2 sponsors
3 locations
NCT07023289
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
PHASE2
Recruiting
140 participants
Started: Aug 7, 2025 · Completed: Nov 30, 2029
1 condition
1 sponsor
17 locations
NCT07091032
Building Connections
NA
Recruiting
3,600 participants
Started: Aug 7, 2025 · Completed: Dec 30, 2029
4 conditions
1 sponsor
1 location
NCT06792825
HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL
PHASE2
Recruiting
65 participants
Started: Aug 7, 2025 · Completed: Jul 8, 2031
2 conditions
2 sponsors
1 location
NCT06556121
Saddle Block With IT Morphine for Penile Inversion Vaginoplasty
NA
Recruiting
40 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06815471
CRF2 Agonist for the Treatment of Worsening Heart Failure
PHASE2
Recruiting
300 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2026
1 condition
2 sponsors
10 locations
NCT06967324
GRACE - Graduated Response for Advanced COPD With Enhanced Support
NA
Recruiting
100 participants
Started: Aug 7, 2025 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT07050433
Correlate Biomarkers for the SYNERGY- 201 Study
N/A
Recruiting
48 participants
Started: Aug 7, 2025 · Completed: Oct 31, 2026
1 condition
2 sponsors
1 location
NCT06854159
Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy
PHASE2
Recruiting
34 participants
Started: Aug 7, 2025 · Completed: Apr 30, 2029
4 conditions
2 sponsors
1 location
NCT07102836
COMPARISON OF ZINC AND PROBIOTICS ON NEONATES WITH INDIRECT HYPERBILIRUBINEMIA UNDERGOING PHOTOTHERAPY
PHASE2
Recruiting
110 participants
Started: Aug 7, 2025 · Completed: May 7, 2026
2 conditions
1 sponsor
1 location
NCT07122245
Demographics of Lung Cancer in Females
N/A
Recruiting
300 participants
Started: Aug 7, 2025 · Completed: Apr 7, 2026
1 condition
1 sponsor
1 location
NCT07094425
Intensive Care Unit-acquired Heart Failure in Critically Ill: the ICU-HF Study
N/A
Recruiting
50 participants
Started: Aug 7, 2025 · Completed: Nov 1, 2026
2 conditions
2 sponsors
2 locations
NCT07124520
A Study of Tongue Strength and Endurance Using the Iowa Oral Performance Instrument (IOPI) Tongue Strength Trainer in People With Oral Tongue Cance
NA
Recruiting
60 participants
Started: Aug 7, 2025 · Completed: Aug 7, 2028
1 condition
1 sponsor
7 locations
NCT06896916
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
PHASE1
Recruiting
135 participants
Started: Aug 7, 2025 · Completed: Mar 31, 2036
1 condition
1 sponsor
14 locations
NCT07098338
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
PHASE2
Recruiting
278 participants
Started: Aug 7, 2025 · Completed: Apr 6, 2029
1 condition
2 sponsors
57 locations
NCT06825403
Olfactory Training in Mild Cognitive Impairment
NA
Recruiting
30 participants
Started: Aug 7, 2025 · Completed: Mar 31, 2028
1 condition
2 sponsors
1 location
NCT06918119
Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida
NA
Recruiting
30 participants
Started: Aug 7, 2025 · Completed: Jul 31, 2030
2 conditions
1 sponsor
1 location
NCT07007793
A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism
PHASE3
Recruiting
180 participants
Started: Aug 7, 2025 · Completed: Feb 18, 2028
1 condition
1 sponsor
88 locations
NCT06865339
Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer
PHASE2
Recruiting
76 participants
Started: Aug 7, 2025 · Completed: Aug 31, 2027
2 conditions
5 sponsors
1 location
NCT06732401
Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer
PHASE3
Recruiting
630 participants
Started: Aug 7, 2025 · Completed: Jun 30, 2028
4 conditions
1 sponsor
116 locations
NCT06923462
VoiceLove: An App-Based COMMunication Tool Designed to Address DeliriUm and Improve Family ENgagement and PatIent/Family SatisfaCtion in CriticAlly Ill PaTiEnts (COMMUNICATE)
NA
Recruiting
100 participants
Started: Aug 6, 2025 · Completed: Mar 15, 2028
2 conditions
1 sponsor
1 location
NCT07158918
ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors
PHASE1/PHASE2
Recruiting
65 participants
Started: Aug 6, 2025 · Completed: Dec 2, 2027
1 condition
2 sponsors
6 locations
NCT06712927
Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases
PHASE2
Recruiting
60 participants
Started: Aug 6, 2025 · Completed: Feb 28, 2030
2 conditions
1 sponsor
1 location
NCT06655207
Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification of Patients, During the Intrapartum Period, Who Are at Higher Risk of Developing Abnormal Postpartum Uterine Bleeding, Including Postpartum Haemorrhage
NA
Recruiting
1,000 participants
Started: Aug 6, 2025 · Completed: Jul 30, 2026
3 conditions
3 sponsors
7 locations
NCT07027072
Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease
PHASE2
Recruiting
114 participants
Started: Aug 6, 2025 · Completed: Dec 31, 2027
3 conditions
1 sponsor
8 locations
Previous
1
More pages
46
47
48
49
50
51
52
More pages
1333
Next